secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K/A
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0000313143-24-000047
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics shareholders elect directors, approve executive pay and auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- All 9 director nominees elected with ~47.1M–47.6M votes each; no director received less than 46.8M for.
- Advisory vote on executive compensation passed with 46.2M for, 1.46M against, 142k abstain.
- Ratification of Ernst & Young as auditor for FY ending March 29, 2025: 47.74M for, 1.05M against.
- Quorum of 48.9M shares (95.99% of outstanding) present at the July 25, 2024 meeting.
- Amendment corrects clerical error in original 8-K regarding fiscal year reference in proposal 3 description.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000047/0000313143-24-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000047/hae-20240725.htm
  HTML page:      https://secwatch.observer/filing/0000313143-24-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer